21615-64-5 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-amino-6-hydroxypyrimidine-4-carboxylate serves as an intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, particularly those targeting diseases such as cancer.
Used in Agrochemical Industry:
methyl 2-amino-6-hydroxypyrimidine-4-carboxylate is also utilized as an intermediate in the production of agrochemicals, contributing to the development of effective solutions for agricultural applications.
Used in Dye and Pigment Manufacturing:
Methyl 2-amino-6-hydroxypyrimidine-4-carboxylate is employed in the manufacturing of certain dyes and pigments, highlighting its significance in the chemical industry for creating a wide range of colorants used in various products.
Overall, methyl 2-amino-6-hydroxypyrimidine-4-carboxylate is a valuable compound with diverse applications, playing a crucial role in the advancement of pharmaceuticals, agrochemicals, and the chemical industry as a whole.
Check Digit Verification of cas no
The CAS Registry Mumber 21615-64-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,6,1 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 21615-64:
(7*2)+(6*1)+(5*6)+(4*1)+(3*5)+(2*6)+(1*4)=85
85 % 10 = 5
So 21615-64-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O3/c1-12-5(11)3-2-4(10)9-6(7)8-3/h2H,1H3,(H3,7,8,9,10)
21615-64-5Relevant academic research and scientific papers
Antagonists of the human A2A receptor. Part 6: Further optimization of pyrimidine-4-carboxamides
Gillespie, Roger J.,Bamford, Samantha J.,Clay, Alex,Gaur, Suneel,Haymes, Tim,Jackson, Philip S.,Jordan, Allan M.,Klenke, Burkhard,Leonardi, Stefania,Liu, Jeanette,Mansell, Howard L.,Ng, Sean,Saadi, Mona,Simmonite, Heather,Stratton, Gemma C.,Todd, Richard S.,Williamson, Douglas S.,Yule, Ian A.
scheme or table, p. 6590 - 6605 (2009/12/24)
Antagonists of the human A2A receptor have been reported to have potential therapeutic benefit in the alleviation of the symptoms associated with neurodegenerative movement disorders such as Parkinson's disease. As part of our efforts to discov
